Search
for
Sort by
Research 121–150 of 321
- Prevalence and Clinical Spectrum of Dermatologic Conditions in Renal Transplant Recipients: A 10-Year Retrospective Cross-Sectional Study
- Hair follicle immune privilege in autoimmune and immune-mediated alopecias: paths toward reestablishing immune tolerance
- Editorial: Exploring innovative therapies for rare inflammatory skin diseases
- Geriatric Dermatologic Therapy
- Responses to Tetanus and Meningococcal Vaccines in Patients with Alopecia Areata Treated with Ritlecitinib
- Coexistence of bullous pemphigoid, intrahepatic cholangiocarcinoma, and alopecia areata: a case report of multifactorial autoimmunity in a surgical context
- ASSOCIATION OF SYSTEMIC LUPUS ERYTHEMATOSUS AND CHRONIC GRANULOMATOUS DISEASE IN ADULTS: REPORT OF 2 CASES
- MIXED CONNECTIVE TISSUE DISEASE EVOLVING FROM THE SEQUENTIAL OVERLAP OF SYSTEMIC LUPUS ERYTHEMATOSUS, SJÖGREN’S SYNDROME, RHEUMATOID ARTHRITIS AND DERMATOMYOSITIS: A FOLLOW-UP
- The Specific Dermatoses of Pregnancy
- Dermatología en la Práctica Médica General Vol. 13
- Autoimmunity and clinical pathology amelioration in SLE by Dexamethasone primed Mesenchymal Stem Cell derived conditioned media
- Navigating Rhupus Complexity
- Navigating Rhupus Complexity
- Skin involvement in systemic lupus erythematosus: a review article
- Dermatological Manifestations of COVID-19: A Brief Review
- Self-Assessment
- FRI0310 Achievement of low disease activity in lupus patients treated with belimumab is independent of serologic status at baseline: a real-life observational study
- Cutaneous lupus erythematosus. Diagnostic and therapeutic recommendations of the Polish Dermatological Society
- Benign Cutaneous Eruptions After Transplantation
- Poster Abstracts
- Cutaneous Lupus Erythematosus
- Subject Index
- Index
- Table of Contents
- Australasian Society for Dermatology Research Meeting, May 2006
- Blinding in Placebo-Controlled Trials
- The Clinical Presentation of Systemic Lupus Erythematosus
- Dermatolojik Problemler ve COVID-19
- Hidradenitis secondary to nirogacestat, a recently approved desmoid tumor medication
- Permanent chemotherapy-induced alopecia after hematopoietic stem cell transplantation treated with low-dose oral minoxidil